[Congressional Record Volume 163, Number 132 (Thursday, August 3, 2017)]
[Senate]
[Page S4787]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
JESSIE'S LAW
Mr. ALEXANDER. Mr. President, I ask unanimous consent that the
Committee on Health, Education, Labor, and Pensions be discharged from
further consideration of S. 581 and the Senate proceed to its immediate
consideration.
The PRESIDING OFFICER. Without objection, it is so ordered.
The clerk will report the bill by title.
The legislative clerk read as follows:
A bill (S. 581) to include information concerning a
patient's opioid addiction in certain medical records.
There being no objection, the Senate proceeded to consider the bill.
Mr. ALEXANDER. Mr. President, I ask unanimous consent that the
Manchin-Capito substitute amendment be agreed to, the bill, as amended,
be considered read a third time and passed, and the motion to
reconsider be considered made and laid upon the table.
The PRESIDING OFFICER. Is there objection?
Without objection, it is so ordered.
The amendment (No. 752) in the nature of a substitute was agreed to,
as follows:
(Purpose: In the nature of a substitute)
Strike all after the enacting clause and insert the
following:
SECTION 1. SHORT TITLE.
This Act may be cited as ``Jessie's Law''.
SEC. 2. INCLUSION OF OPIOID ADDICTION HISTORY IN PATIENT
RECORDS.
(a) Best Practices.--
(1) In general.--Not later than 1 year after the date of
enactment of this Act, the Secretary of Health and Human
Services, in consultation with appropriate stakeholders,
including a patient with a history of opioid use disorder, an
expert in electronic health records, an expert in the
confidentiality of patient health information and records,
and a health care provider, shall identify or facilitate the
development of best practices regarding--
(A) the circumstances under which information that a
patient has provided to a health care provider regarding such
patient's history of opioid use disorder should, only at the
patient's request, be prominently displayed in the medical
records (including electronic health records) of such
patient;
(B) what constitutes the patient's request for the purpose
described in subparagraph (A); and
(C) the process and methods by which the information should
be so displayed.
(2) Dissemination.--The Secretary shall disseminate the
best practices developed under paragraph (1) to health care
providers and State agencies.
(b) Requirements.--In identifying or facilitating the
development of best practices under subsection (a), as
applicable, the Secretary, in consultation with appropriate
stakeholders, shall consider the following:
(1) The potential for addiction relapse or overdose,
including overdose death, when opioid medications are
prescribed to a patient recovering from opioid use disorder.
(2) The benefits of displaying information about a
patient's opioid use disorder history in a manner similar to
other potentially lethal medical concerns, including drug
allergies and contraindications.
(3) The importance of prominently displaying information
about a patient's opioid use disorder when a physician or
medical professional is prescribing medication, including
methods for avoiding alert fatigue in providers.
(4) The importance of a variety of appropriate medical
professionals, including physicians, nurses, and pharmacists,
to have access to information described in this section when
prescribing or dispensing opioid medication, consistent with
Federal and State laws and regulations.
(5) The importance of protecting patient privacy, including
the requirements related to consent for disclosure of
substance use disorder information under all applicable laws
and regulations.
(6) All applicable Federal and State laws and regulations.
The bill (S. 581), as amended, was ordered to be engrossed for a
third reading, was read the third time, and passed.
____________________